Verifarma is a leading provider of integrated software solutions for the pharmaceutical and life sciences industry, spanning serialization and traceability, quality management (eQMS), regulatory affairs, and pharmacovigilance.
2026
Year invested
Fund II
MTIP Fund
Canary Islands, Spain
Location
Investment status
Track & Trace
Segment
Verifarma provides software solutions for the pharmaceutical and life sciences industry, enabling end-to-end traceability, regulatory compliance, and supply chain transparency. Its platform supports manufacturers, wholesalers, and distributors in meeting global requirements while ensuring the safety and authenticity of medicines.
Serving over 2,000 companies across 26 countries, Verifarma has established a strong presence in Latin America and is expanding across Europe. In addition to its core track-and-trace solutions, the company offers a growing suite of quality management (eQMS) and regulatory software, supported by a team of industry experts dedicated to delivering reliable and scalable solutions.
As a long-term investor with a track record of creating successful and sustainable businesses, our goal is to deliver attractive strategic and financial returns to our investors.
.svg)
.svg)
.png)
